Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (201-210 of 431) with videos related to

Pageof 44
Sort By:
Calcified Tissue International|March 2, 2018
Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?Athanasios D Anastasilakis, Symeon Tournis, Maria P Yavropoulou, et al.
Current Obesity Reports|May 2, 2022
Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver DiseaseStergios A Polyzos, Dimitrios G Goulis, Olga Giouleme, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 21, 2019
Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosisMarina Boziki, Nikolaos Grigoriadis, Michael Doulberis, et al.
Journal of Personalized Medicine|July 29, 2023
Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisMyrsini Orfanidou, Charikleia Ntenti, Kleo Evripidou, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 21, 2020
Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be EnoughAthanasios D Anastasilakis, Georgios Trovas, Alexia Balanika, et al.
Clinical Endocrinology|March 5, 2013
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosisPolyzois Makras, Stergios A Polyzos, Athanasios Papatheodorou, et al.
Endocrine|October 15, 2016
Circulating periostin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Endocrine|August 11, 2020
A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatmentZoe A Efstathiadou, Charilaos Kostoulas, Stergios A Polyzos, et al.
Journal of Clinical and Experimental Hepatology|March 4, 2024
Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisEleftheria Makri, Myrsini Orfanidou, Evangelia S Makri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 26, 2024
The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis and the missing link: Helicobacter pylori infectionMichael Doulberis, Apostolis Papaefthymiou, Evangelos Kazakos, et al.
Pageof 44

Showing results (201-210 of 431) with videos related to

Sort By:
Pageof 44
Calcified Tissue International|March 2, 2018
Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?Athanasios D Anastasilakis, Symeon Tournis, Maria P Yavropoulou, et al.
Current Obesity Reports|May 2, 2022
Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver DiseaseStergios A Polyzos, Dimitrios G Goulis, Olga Giouleme, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 21, 2019
Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosisMarina Boziki, Nikolaos Grigoriadis, Michael Doulberis, et al.
Journal of Personalized Medicine|July 29, 2023
Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisMyrsini Orfanidou, Charikleia Ntenti, Kleo Evripidou, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 21, 2020
Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be EnoughAthanasios D Anastasilakis, Georgios Trovas, Alexia Balanika, et al.
Clinical Endocrinology|March 5, 2013
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosisPolyzois Makras, Stergios A Polyzos, Athanasios Papatheodorou, et al.
Endocrine|October 15, 2016
Circulating periostin in patients with nonalcoholic fatty liver diseaseStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Endocrine|August 11, 2020
A mutation in NOTCH2 gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatmentZoe A Efstathiadou, Charilaos Kostoulas, Stergios A Polyzos, et al.
Journal of Clinical and Experimental Hepatology|March 4, 2024
Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisEleftheria Makri, Myrsini Orfanidou, Evangelia S Makri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 26, 2024
The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis and the missing link: Helicobacter pylori infectionMichael Doulberis, Apostolis Papaefthymiou, Evangelos Kazakos, et al.
Pageof 44